Soluble TNF and IL-6 receptors: Indicators of vascular health in women without cardiovascular disease

Vascular Medicine (United Kingdom)

Volumn 18, Issue 5, 2013, Pages 282-289

  Cortez Cooper, Miriam ^a   Meaders, Eric ^a   Stallings, Judith ^a   Haddow, Sara ^a   Kraj, Barbara ^a   Sloan, Gloria ^a   McCully, Kevin K ^b   Cannon, Joseph G ^a  

^a AUGUSTA UNIVERSITY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

atherosclerosis; cytokines; endothelium; monocytes; vascular

Indexed keywords

CYTOKINE RECEPTOR; GLYCOPROTEIN GP 130; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1 RECEPTOR TYPE II; INTERLEUKIN 1BETA RECEPTOR; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 6 RECEPTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG;

ADULT; ARTERIAL WALL THICKNESS; ARTERY BLOOD FLOW; ARTICLE; BRACHIAL ARTERY FLOW MEDIATED DILATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY PULSE; CLINICAL INDICATOR; CORRELATION ANALYSIS; CYTOKINE RELEASE; FEMALE; FEMORAL ARTERY PULSE; HUMAN; IN VITRO STUDY; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PULSE WAVE; ULTRASOUND TRANSDUCER;

ATHEROSCLEROSIS; CYTOKINES; ENDOTHELIUM; MONOCYTES; VASCULAR;

ADULT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CYTOKINES; FEMALE; HUMANS; MIDDLE AGED; PULSE WAVE ANALYSIS; RECEPTORS, CYTOKINE; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-6; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RISK FACTORS; SOLUBILITY; VASCULAR STIFFNESS; YOUNG ADULT;

EID: 84887013838     PISSN: 1358863X     EISSN: 14770377     Source Type: Journal    
DOI: 10.1177/1358863X13508336     Document Type: Article

References (51)

1. Bautista LE. Inflammation, endothelial dysfunction, and risk of high blood pressure: epidemiologic and biological evidence. J Hum Hypertens. 2003 ; 17: 223-230
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005 ; 352: 1685-1695
3. Van Bussel BC, Schouten F, Henry RM, et al. Endothelial dysfunction and low-grade inflammation are associated with greater arterial stiffness over a 6-year period. Hypertens. 2011 ; 58: 588-595
4. Muller DN, Kvakan H, Luft FC. Immune-related effects in hypertension and target-organ damage. Curr Opin Nephrol Hypertens. 2011 ; 20: 113-117
5. Biascucci LM, Liuzzo G, Fantuzzi G, et al. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation. 1999 ; 99: 2079-2084
6. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000 ; 342: 836-843
7. Fernandez-Botran R. Soluble cytokine receptors: Their role in immunoregulation. FASEB J. 1991 ; 5: 2567-2574
8. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med. 1992 ; 175: 323-329
9. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood. 1991 ; 77: 1627-1652
10. Jones SA, Richards PJ, Scheller J, Rose-John S. IL-6 trans-signaling: The in vivo consequences. J Interferon Cytokine Res. 2005 ; 25: 241-253
11. Rose-John S, Scheller J, Elson G, Jones SA. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: Role in inflammation and cancer. J Leuk Biol. 2006 ; 80: 227-236
12. Ueland T, Kjekshus J, Froland SS, et al. Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients. J Am Coll Cardiol. 2005 ; 46: 2018-2021
13. Valgimigli M, Cecone C, Malgutti P, et al. Tumor necrosis factor-α receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction. Circulation. 2005 ; 111: 863-870
14. Cannon JG, Cortez-Cooper M, Meaders E, et al. Follicle-stimulating hormone, interleukin-1, and bone density in adult women. Am J Physiol Regul Integr Comp Physiol. 2010 ; 298: R790 - R798
15. Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003 ; 35: 1381-1395
16. Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006 ; 27: 2588-2605
17. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992 ;: 1111-1115
18. Bland M An Introduction to Medical Statistics. 3 rd edition.New York: Oxford University Press, 2000, pp. 148-151. New York: Oxford University Press ; 2000: 148-151.
19. Motulsky HJ, Brown RE. Detecting outliers when fitting data with nonlinear regression - A new method based on robust nonlinear regression and false discovery rate. BMC Bioinformatics. 2006 ; 7: 123
20. Haskell WL, Lee IM, Pate RR, et al. Physical activity and public health: Updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007 ; 39: 1423-1434
21. Hu R, Wang WQ, Lau CP, Tse HF. Gender differences on brachial flow-mediated dilation and carotid intima-media thickness for prediction of spontaneous cardiovascular events. Clin Cardiol. 2008 ; 31: 525-530
22. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J. 2010 ; 31: 2338-2350
23. Modur V, Li Y, Zimmerman GA, Prescott SM, McIntyre TM. Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha. J Clin Invest. 1997 ; 100: 2752-2756
24. Hung MJ, Cherng WJ, Hung MY, Wu HT, Pang JH. Interleukin-6 inhibits endothelial nitric oxide synthase activation and increases endothelial nitric oxide synthase binding to stabilized caveolin-1 in human endothelial cells. J Hypertens. 2010 ; 28: 940-951
25. Sironi M, Breviario F, Proserpio P, et al. IL-1 stimulates IL-6 production in endothelial cells. J Immunol. 1989 ; 142: 549-553
26. Jones SA, Horiuchi S, Novick D, Yamamoto N, Fuller GM. Shedding of the soluble IL-6 receptors is triggered by Ca2+ mobilization, while basal release is predominantly the product of differential mRNA plicing in THP-1 cells. Eur J Immunol. 1998 ; 28: 3514-3522
27. Deng T-L, Yu L, Ge Y-K, Zhang L, Zheng X-X. Intracellular free calcium dynamics and F-actin alteration in the formation of macrophage foam cells. Biochem Biophys Res Commun. 2005 ; 338: 748-756
28. Negre-Salvayre A, Dousset N, Ferretti G, Bacchetti T, Curatola G, Salvayre R. Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells. Free Radic Biol Med. 2006 ; 41: 1031-1040
29. Murphy AJ, Woollard KJ, Hoang A, et al. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol. 2008 ; 28: 2071-2077
30. Hyka N, Dayer J-M, Modoux C, et al. Apolipoprotein A-I inhibits the production of interleukin-1β and tumor necrosis factor-α by blocking contact-mediated activation of monocytes by T lymphocytes. Blood. 2001 ; 97: 2381-2389
31. Tang C, Liu Y, Kessler PS, Vaughan AM, Oram JF. The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor. J Biol Chem. 2009 ; 284: 32,336-32,343
32. Kim KD, Lim HY, Lee HG, et al. Apolipoprotein A-I induces IL-10 and PGE2 production in human monocytes and inhibits dendritic cell differentiation and maturation. Biochem Biophys Res Commun. 2005 ; 338: 1126-1136
33. Lee S-Y, Zaske A-M, Novellino T, et al. Probing the mechanical properties of TNFα-stimulated endothelial cell with atomic force microscopy. Int J Nanomedicine. 2011 ; 6: 179-195
34. Young W, Mahboubi K, Haider A, Li I, Ferrari NR. Cyclooxygenase-2 is required for tumor necrosis factor-α- and angiotensin II-mediated proliferation of vascular smooth muscle cells. Circ Res. 2000 ; 86: 906-914
35. Theiss AL, Simmons JG, Jobim C, Lund PK. Tumor necrosis factor (TNF) α increases collagen accumulation and proliferation in intestinal myofibroblasts via THF receptor 2. J Biol Chem. 2005 ; 280: 36,099-36,109
36. Angel K, Provan SA, Fagerhol MK, Mowinckel P, Kvien TK, Atar D. Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthopathies: A controlled study. Am J Hypertens. 2012 ; 25: 644-650
37. Wong M, Oakley SP, Young L, et al. Infliximab improves vascular stiffness in patients with rheumatoid arthritis. Ann Rheum Dis. 2009 ; 68: 1277-1284
38. Ohgushi M, Taniguchi A, Fukushima M, et al. Soluble tumor necrosis factor receptor 2 is independently associated wtih pulse wave velocity in nonobese Japanese patients with type 2 diabetes mellitus. Metabolism. 2007 ; 56: 571-577
39. Rauchhaus M, Doehner W, Francis DP, et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation. 2000 ; 102: 3060-3067
40. Elkind MS, Cheng J, Boden-Albala B, et al. Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke. 2002 ; 33: 31-38
41. Dibbs Z, Thornby J, White BG, Mann DL. Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: Implications for clinical trials. J Am Coll Cardiol. 1999 ; 33: 1935-1942
42. Kullo IJ, Malik AR. Arterial ultrasonography and tonometry as adjuncts to cardiovascular risk stratification. J Am Coll Cardiol. 2007 ; 49: 1413-1426
43. Speeckaert MM, Speeckaert R, Laute M, Vanholder R, Delanghe JR. Tumor necrosis factor receptors: Biology and therapeutic potential in kidney diseases. Am J Nephrol. 2012 ; 36: 261-270
44. Bjornberg F, Lantz M. Adherence to endothelial cells induces release of soluble tumor necrosis factor (TNF) receptor forms from neutrophil granulocytes. Biochem Biophys Res Commun. 1998 ; 244: 594-598
45. Leeuwenberg JFM, Dentener MA, Buurman WA. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. J Immunol. 1994 ; 152: 5070-5076
46. Xanthoulea S, Gijbels MJJ, van der Made I, et al. p55 Tumor necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice. Cardiovasc Res. 2008 ; 80: 309-318
47. Endres S, Whitaker RE, Ghorbani R, Meydani SN, Dinarello CA. Oral aspirin and ibuprofen increase cytokine-induced synthesis of IL-1 beta and tumor necrosis factor alpha ex vivo. Immunology. 1996 ; 87: 264-270
48. Cannon JG, Pierre BAS. Gender differences in host defense mechanisms. J Psychiatr Res. 1997 ; 31: 99-113
49. Black MA, Cable NT, Thijssen DHJ, Green DJ. Impact of age, sex and exercise on brachial artery flow-mediated dilatation. Am J Physiol. 2009 ; 297: H1109 - H1116
50. Pierce GL, Eskurza I, Walker AE, Fay TN, Seals DR. Sex-specific effects of habitual aerobic exercise on brachial artery flow-mediated dilation in middle-aged and older adults. Clin Sci. 2010 ; 120: 13-23
51. Toikka JO, Ahotupa M, Viikari JS, et al. Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young men. Atherosclerosis. 1999 ; 147: 133-138